Understanding FDA Enforcement in 503A and 503B Compounding Pharmacies
FDA Enforcement and Compliance for 503A and 503B Compounding Facilities
Regulatory scrutiny of the US compounding sector continues to intensify, placing greater emphasis on the quality systems, processes and controls underpinning both 503A compounding pharmacies and 503B outsourcing facilities.
Written by scientists at Cormica TPM and published in Advances in Chemical Engineering and Science, ‘The Compounding Enforcement Wave: Drivers, Deficiencies, and a Quality System Roadmap for 503A and 503B Facilities’, examines recent FDA enforcement activity and the recurring deficiencies contributing to Form 483 observations, warning letters, recalls and other regulatory actions.
Understanding the Current FDA Enforcement Landscape
The article explores the important regulatory distinction between 503A pharmacies and 503B outsourcing facilities, including the mandatory cGMP requirements applicable to 503B facilities under 21 CFR Parts 210 and 211.
Drawing on FDA enforcement records and recent industry data, the authors examine recurring compliance concerns across aseptic processing, environmental monitoring, sterility assurance, beyond-use dating, cleaning validation, investigations and CAPA, API sourcing, labelling and adverse event reporting.
Key areas include:
- The regulatory differences between 503A and 503B facilities
- Common FDA inspection findings and relevant CFR requirements
- Sterility assurance and environmental monitoring
- Stability studies and beyond-use date justification
- Cleaning validation
- Investigations and CAPA
- API sourcing and supplier controls
- Labelling and adverse event reporting
Supporting Your Quality and Testing Programme
Across our global laboratory network, expert scientists support pharmaceutical organisations with many of the testing activities referenced throughout the article. This includes analytical method development, validation and transfer, potency and identity testing, stability studies, sterility and bacterial endotoxin testing, cleaning validation, container closure integrity testing and wider microbiological support.
With decades of regulated laboratory experience and work completed for clients worldwide, our teams can help generate robust scientific data, address testing gaps and support quality programmes throughout product development, routine testing and regulatory inspection readiness.
Download:
We will email you the link to the PDF file.
Authors:
Mem Rani
Mem hold a master’s degree in Chemistry and have more than six years of pharmaceutical laboratory experience. Her expertise includes GC, HPLC, method validation, cGMP testing, data documentation, and laboratory compliance.
Mounika Duppala
Mounika Duppala is an Analytical Chemist at Cormica TPM. She holds master’s degrees in Regulatory Science and Analytical Chemistry and supports pharmaceutical testing in GMP-regulated environments.
Megha Darji
Megha Darji is an Analytical Chemist at Cormica TPM. Holding a Bachelor of Pharmacy, they support GMP pharmaceutical testing, sample management and laboratory documentation, with a strong focus on data integrity and quality.
Nansiben Patel
Nansi joined Cormica in 2025 and works as an Analytical Chemist. She holds a master’s degree in Biotechnology and has over nine years of experience in pharmaceutical testing, method development and validation.
Alyssa Ragusa joined Cormica TPM in December 2025. She holds degrees in Chemical Biology and Chemistry and is currently completing a PhD at Rowan University, with research focused on HPLC column development.
Dr Kishore Hotha is General Manager of TPM. With more than 20 years of international experience, he has supported over 100 regulatory submissions, led teams through FDA audits and authored more than 100 scientific publications.
Cormica's Webinars
Recent News
Technical Resources
Laboratories near you, supporting global product success
With accredited laboratories in the UK, EU and US, we support pharmaceutical, medical device and combination product manufacturers worldwide. Local support combined with global quality, delivered by teams who understand your regulatory requirements.
Our Clients’ Experiences
